Surgery Godfather-Chapter 1857 - 1296: Blossoming Everywhere (Part 2)
Yang Ping nodded: "You and President Huang can arrange this matter."
"Okay, we’ll discuss it later." Huang Jiacai patted Song Zimo’s shoulder.
Yang Ping ate a few dumplings and suddenly said: "President Huang, where did you buy these dumplings? They taste quite good."
Huang Jiacai froze for a moment, then laughed: "Jiahui made them herself; she asked me to bring them to you."
"Jiahui’s cooking is pretty good!" Song Zimo also praised.
Huang Jiacai gave a mysterious smile: "She didn’t let you eat for free; she said she wants you to introduce her to a doctor or researcher from your institute."
Song Zimo didn’t expect Huang Jiacai’s sister was also interested in the men at the institute: "Conditions?"
"Male, unmarried, alive..." Huang Jiacai counted the conditions on his fingers, "Just these three conditions."
...
Germany at Munich, Charite Hospital’s oncology department, nine o’clock in the morning.
Dr. Hans Mueller stood at the door of Ward 5, taking a deep breath. In his hands, he held a silver metal tray, with a 100 ml bottle of transparent liquid fixed in the center, labeled with bilingual "K biological agent" and a complex barcode batch number. The liquid emitted a very faint pale blue fluorescence in the morning light — it was the optical marker characteristic of the recombinant adenovirus vector carrying the K Factor.
Beside him stood a nurse, and Dr. Li Guodong, from China, who was one of the first doctors at Sanbo Hospital to receive K Therapy training. He had been dispatched by Song Zimo to Germany to serve as a training instructor, responsible for guiding the limited clinical trials here as Charite Hospital’s oncology department would establish one of Europe’s three major K Therapy centers.
Besides Dr. Li Guodong, there were also Manstein, August, and over ten doctors with serious expressions.
In the ward, the forty-two-year-old osteosarcoma patient, Thomas Berg, was ready. He lay half-reclined on the hospital bed, his right arm’s indwelling needle connected to the infusion line. Contrary to the imagined tragic scene of fighting tumors, there were no shadowless lamps, no complex surgical instruments, just a regular monitor and a face that looked slightly fatigued but full of hope.
"Good morning, Mr. Berg," Hans said in German, his voice steady, "Let me confirm once again: You have thoroughly understood the principles of K Therapy, the possible risks of immune reactions, and signed the informed consent?"
Thomas nodded, his voice sounding somewhat hoarse from multiple chemotherapy and radiation therapy sessions: "Yes, doctor, I have checked all the information and watched Li Gaoyang’s case. This seems much simpler than the chemotherapy and radiation therapy I’ve experienced."
"The process is simple, but the monitoring behind it is not." Hans connected the agent bottle to the infusion pump, setting the precise flow rate at 5 ml per minute, requiring twenty minutes for the entire infusion process. "In the next hour, doctors and nurses will continuously monitor your vital signs. You will need to stay in the hospital for observation in the next two weeks. Most importantly, every drop of medicine in your body will be transmitted in real time to the analysis center in China."
"I understand!"
Thomas looked at the transparent liquid slowly infused into his vein, his expression complex. Inside were genetically modified adenoviruses that, once entering the bloodstream, would act like smart missiles, relying on virus surface-modified targeting proteins to accurately recognize and infect tumor cells in his body with specific surface markers. Then, the gene carried by the virus with the K Factor would express itself inside the tumor cells, initiating programmed apoptosis signaling to make the cancer cells "commit suicide," while avoiding harm to normal cells.
The entire process was very complex, but on the surface, it seemed just like an ordinary infusion.
Hans, with the nurse’s assistance, completed the operation and stepped aside. Over ten doctors stood around with serious expressions, watching with a reverent heart the most cutting-edge tumor treatment method in the world, each one of them having their eyes wide open to avoid missing any detail.
A trolley held a high-definition screen divided into three sections: The left side showed Thomas’s real-time vital signs, the middle presented the South China Sanbo Research Institute’s data monitoring center footage, and the right side displayed a simulated animation of adenovirus distribution in the body with blue light spots representing the virus converging from peripheral veins towards the heart, then pumping towards the whole body and slowly gathering at the tumor’s location.
In the small central window of the screen, Yang Ping appeared. In China, it was a little after four in the afternoon; he seemed to have just left the laboratory, not yet removing his white gown.
"Hello everyone!" Yang Ping greeted everyone.
August and Manstein, regardless of their status among these doctors, excitedly waved to Professor Yang first: "Hello, Professor!"
"Hello!" Yang Ping responded.
"Dr. Mueller, is the patient’s condition stable?"
Yang Ping asked in Chinese, but it didn’t matter, as all the doctors selected here had a good level of Chinese proficiency; those without a certain level of Chinese were not eligible to receive K Therapy training because all the materials and training related to K Therapy were in Chinese.
"Vital signs are stable, five minutes since infusion began, no adverse reactions," Hans reported. 𝒻𝘳𝘦𝘦𝘸ℯ𝒷𝘯𝘰𝑣ℯ𝑙.𝘤𝑜𝘮
"Observe closely for any acute allergic-like reactions in the first fifteen minutes, although the incidence rate is less than one in one hundred thousand, we must remain vigilant."
"Understood."
Listening to the conversation between the two doctors, Thomas suddenly asked in English: "Professor Yang, I’ve read online that this virus might go out of control or mutate, is that true?"
On the screen, Yang Ping turned towards the camera, his expression calm and serious: "Mr. Berg, the adenovirus vector you’ve been intravenously infused with has undergone multiple genetic modifications. First of all, it has had the replication-essential genes deleted, making it unable to self-replicate and proliferate inside the human body; secondly, its targeting has been rigorously validated, identifying only special markers on tumor cell surfaces; thirdly, this adenovirus itself is commonly used as a vector, and is one of the safe viruses for humans, so you don’t have to worry about these issues at all."
August and Manstein scrambled to translate, but Manstein got ahead, with Yang Ping’s explanation being professional and straightforward, not containing any soothing words, which reassured Thomas.
By the twentieth minute of the infusion, the last drop of liquid entered the body. Apart from feeling a bit cold at the infusion site on his arm, Thomas felt no special sensations.
"It’s... over?" he said, somewhat incredulously.
"The drug delivery has ended, but the treatment has just begun," Hans said, looking at the monitor, "The viral vectors are now searching for targets in your blood circulation. In the next 24 to 72 hours, the infected tumor cells will begin to undergo apoptosis, and your immune system will be activated to clear these cellular debris, of course, it might also be activated to attack our K biological agent, in which case you might experience flu-like symptoms — fever, muscle aches, fatigue, which are signs of treatment efficacy, and we will use medication to help control them."
Thomas lay back on his pillow, closing his eyes.
Over the past eight months, he had experienced the collapse at diagnosis, the torture of chemotherapy, the burning pain of radiation therapy, and the despair of hope crumbling again and again. Yet today, the battle against late-stage osteosarcoma was as quiet as an ordinary afternoon infusion.
Lillian Windsor, who flew in from London, hurried to witness this treatment and was glad not to have missed it. Having fully recovered, she came this time as a representative of the foundation to witness Europe’s first local K Therapy volunteer.
"Dr. Mueller, how do you feel?" Lady Windsor asked.
"Like completing a routine operation, but also feeling like part of history," Hans said honestly. "Previously, our means of fighting late-stage solid tumors were limited and painful. Now a single bottle of medication takes only twenty minutes."
"But behind this bottle is the genius’s masterpiece!" Lillian looked towards Yang Ping on the screen.
Everyone silently watched the monitoring data; at the molecular level unseen by Thomas, billions of modified viruses were executing a precise annihilation battle within his body.
